Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for TLRY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
May 31, 2026 1.614B
February 28, 2026 1.557B
November 30, 2025 1.580B
August 31, 2025 1.541B
May 31, 2025 1.511B
February 28, 2025 2.730B
November 30, 2024 3.473B
August 31, 2024 3.478B
May 31, 2024 3.443B
February 29, 2024 3.359B
November 30, 2023 3.368B
August 31, 2023 3.379B
May 31, 2023 3.316B
February 28, 2023 3.404B
November 30, 2022 4.470B
August 31, 2022 4.525B
Date Value
May 31, 2022 4.399B
February 28, 2022 4.627B
November 30, 2021 4.436B
August 31, 2021 4.319B
December 31, 2020 373.90M
September 30, 2020 186.72M
June 30, 2020 131.49M
March 31, 2020 190.31M
December 31, 2019 285.27M
September 30, 2019 415.75M
June 30, 2019 360.17M
March 31, 2019 381.92M
December 31, 2018 197.65M
September 30, 2018 188.11M
June 30, 2018 35.23M
March 31, 2018 42.64M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
SNDL, Inc. 749.74M
cbdMD, Inc. 8.212M
Clearmind Medicine, Inc. 11.49M
CannaPharmaRx, Inc. -30.83M
Cosmos Health, Inc. 20.67M

Shareholders Equity (Quarterly) Related Metrics